CDH2 and neoplasm: Loss of KLF10 led to the upregulation of the mesenchymal cell markers N-cadherin and SNAI2 and the invasiveness markers MMP2 and MMP9. KLF10 inhibition enhanced the metastatic function of liver cancer cells and the tumor-enabling function of HSCs.